# Ensemble

> Ensemble is a VC fund in San Francisco backing Cannabis and Software. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 10
- Last investment: Dec 2023
- Lead investor: 30%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ensemble-brands
- Website: http://www.ensemblebrands.com

Ensemble is a venture capital firm that focuses on investing in cannabis ecosystem.

## Contacts

5 contacts available for Ensemble. Shizune tracks 1 team members at Ensemble. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ensemble-brands?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Cannabis | 6 | 60% |
| Software | 6 | 60% |
| SaaS | 2 | 20% |
| AgTech | 2 | 20% |
| Wellness | 2 | 20% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 30% |
| Pre-Seed | 2 | 20% |
| Convertible Note | 2 | 20% |
| Series A | 1 | 10% |
| Series C | 1 | 10% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Reed Woodson | Managing Partner | 1 | https://shizune.co/investors/profile/reed-woodson-a57f |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Radicle Science | AI-driven healthtech B-Corp providing history's first Proof-as-a-Service solution for non-pharmaceuticals to easily prove their true effects. | $2.8M | Convertible Note | Dec 15, 2023 |  |
| Serve AI | Genetica provides exact product suggestions, guaranteeing that clients obtain the best product for their wants, biochemistry, and current in-store availability. | $500K | Seed | May 24, 2023 |  |
| Happy Cabbage Analytics | Happy Cabbage Analytics provides a data analytics and insights platform for the cannabis industry. It focuses on bridging the gap between data and action via the integration of analytics, pricing, and marketing into a single automated platform. |  | Venture - Series Unknown | Nov 14, 2022 |  |
| Komplyd | Komplyd is an enterprise-class cannabis technology platform that manages risk and compliance easily. Komplyd’s API provides enriched data, increasing the team’s productivity. It provides real-time and accurate compliance updates. It is a common data model and a single endpoint that empowers the team to rapidly deliver cannabis compliance solutionsin days. |  | Seed | Aug 09, 2022 |  |
| Nugget | Building a new product in the cannabis tech industry |  | Pre-Seed | Aug 01, 2022 |  |
| Trym | Trym empowers cannabis cultivators to make informed decisions to improve operational efficiency, maintain consistency, grow revenues, and increase their competitive advantage. |  | Series A | Jul 15, 2022 |  |
| Happy Cabbage Analytics | Happy Cabbage Analytics provides a data analytics and insights platform for the cannabis industry. It focuses on bridging the gap between data and action via the integration of analytics, pricing, and marketing into a single automated platform. |  | Convertible Note | Jun 15, 2022 |  |
| Open Book Extracts | Open Book Extracts is a cGMP certified, vertically integrated grower, processor, and manufacturer of premium plant-based products. With control of the entire supply chain, a state-of-the-art extraction campus near North Carolina’s Research Triangle, proprietary refinement and conversion methods backed by a growing IP portfolio, and a team of Ph.D.chemists and seasoned business leaders, OBX is the trusted partner for global brands seeking to enter the marketplace. OBX Asia, with its headquarters in Hong Kong, provides strategic guidance and on-the-ground support for our Asia customers.OBX’s cGMP-certified productions operations are led by a seasoned science team, including a Ph.D. food scientist from Cornell, a Ph.D. organic chemist from the University of Nevada, and two masters chemists with pharmaceutical backgrounds, including a quality control director who joined OBX after a 15-year career as an analytical chemist at GlaxoSmithKline. OBX offers one of the largest portfolios of cannabinoid isolates at 99%+ purity, including CBD, CBG, CBN, CBC, and THCV, as well as formulation services and turnkey, finished good manufacturing including edibles, soft gels, tablets, tinctures, pet products, and topical products. |  | Series C | Apr 06, 2022 |  |
| Radicle Science | AI-driven healthtech B-Corp providing history's first Proof-as-a-Service solution for non-pharmaceuticals to easily prove their true effects. |  | Seed | Mar 30, 2022 |  |
| Ordo | Ordo is a wholesale management platform that helps cannabis brands launch, scale, and grow. A CRM built for the needs of cannabis sales teams. With an emphasis on simplicity, we give reps tools that actually help in performing the unique job functions found in the cannabis wholesale sector.Founded in 2020 and headquartered in Los Angeles,California. |  | Pre-Seed | Jan 01, 2021 |  |

10 of 10 investments shown.

## Co-investors
- [Ensemble Brands](https://shizune.co/investors/profile/ensemble-brands-2d7b) — VC Fund, 2 deals together
- [Poseidon Asset Management](https://shizune.co/investors/profile/poseidon-assetmanagement) — VC Fund, 2 deals together
- [Achari Ventures](https://shizune.co/investors/profile/achari-ventures) — VC Fund, 1 deal together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [Delta Emerald Ventures](https://shizune.co/investors/profile/delta-emerald-ventures) — VC Fund, 1 deal together
- [Emerging Ventures](https://shizune.co/investors/profile/emerging-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Casa Verde Capital](https://shizune.co/investors/profile/casa-verde-capital) — VC Fund
- [Poseidon Asset Management](https://shizune.co/investors/profile/poseidon-assetmanagement) — VC Fund
- [Phyto Partners](https://shizune.co/investors/profile/phyto-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## Featured in investor lists
- [Cannabis VC Funds](https://shizune.co/investors/cannabis-vc-funds)
- [Cannabis Investors](https://shizune.co/investors/cannabis-investors)

## FAQ

### What does Ensemble invest in?

Ensemble invests primarily in Cannabis, Software and SaaS startups, most often at Seed and Pre-Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ensemble?

Public channels for Ensemble include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Ensemble?

The team at Ensemble includes Reed Woodson (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co